IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1676 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
   Article in PDF (105 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   Abstract
   Introduction
   Materials and me...
   Results
   Discussion
   References
   Article Tables

 Article Access Statistics
    Viewed10826    
    Printed199    
    Emailed14    
    PDF Downloaded365    
    Comments [Add]    
    Cited by others 18    

Recommend this journal

 


 
STUDIES
Year : 2005  |  Volume : 71  |  Issue : 4  |  Page : 246-249

Correlation of the severity of atopic dermatitis with absolute eosinophil counts in peripheral blood and serum IgE levels


1 Departments of Dermatology, Institute of Child Health, Kolkata, India
2 Departments of Pediatrics, Institute of Child Health, Kolkata, India
3 Department of Pathology, AMRI-Apollo Hospitals, Kolkata, India

Correspondence Address:
Sandipan Dhar
Flat 2A2, Block 2, 5, N.S.C. Bose Road, Kolkata - 700 040
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.16615

Rights and Permissions

  Abstract 

BACKGROUND: Although a number of epidemiological studies, showing incidence and prevalence of atopic dermatitis, were available, scant attention has been paid to the correlation between the parameters of the disease like severity, absolute eosinophil count and IgE level, which has been known to be associated inconsistently. Hence this study was undertaken. METHODS: A total of 102 patients of atopic dermatitis, both children and adults, and 107 age matched controls were studied at the Pediatric Dermatology clinic, Institute of Child Health and department of Dermatology, AMRI-Apollo hospitals, Kolkata. RESULTS: The average age of onset of atopic dermatitis was observed to be 4.55 years. Both the average absolute eosinophil count and IgE levels in patients of atopic dermatitis were significantly higher than that of the controls. Each of these parameters showed significant correlation with severity of the disease and showed a nonhomogeneous distribution reflected by significant association with personal history of bronchial asthma and family history of atopy, when both parents were atopic. CONCLUSIONS: Our study shows that clinical activity of the disease as recorded by the "SCORAD" index can be used as an indicator of the hematological abnormalities as well as to some extent as a prognostic indicator. Family history of atopy correlates with the hematological abnormalities only if both parents are involved and bronchial asthma is the only associated atopic condition which correlates with the parameters of the disease .


Keywords: Eosinophil, IgE, Atopic dermatitis


How to cite this article:
Dhar S, Malakar R, Chattopadhyay S, Dhar S, Banerjee R, Ghosh A. Correlation of the severity of atopic dermatitis with absolute eosinophil counts in peripheral blood and serum IgE levels. Indian J Dermatol Venereol Leprol 2005;71:246-9

How to cite this URL:
Dhar S, Malakar R, Chattopadhyay S, Dhar S, Banerjee R, Ghosh A. Correlation of the severity of atopic dermatitis with absolute eosinophil counts in peripheral blood and serum IgE levels. Indian J Dermatol Venereol Leprol [serial online] 2005 [cited 2017 Nov 23];71:246-9. Available from: http://www.ijdvl.com/text.asp?2005/71/4/246/16615



  Introduction Top


Atopic dermatitis (AD) is an itchy, chronic, or chronically relapsing inflammatory skin condition. The rash is characterized by itchy papules (occasionally vesicles in infants) that become excoriated and lichenified, and typically have a flexural distribution. The eruption is frequently associated with other atopic conditions in the individual or in other family members. [1],[2],[3],[4] The main immunological abnormalities are excessive formation of IgE, with a predisposition to anaphylactic sensitivity, some decrease in susceptibility to delayed hypersensitivity, abnormalities in expression of surface molecules in antigen presenting cells, and dysregulation of cytokine mediators. The severity of AD has some positive correlation with the absolute eosinophil count and serum IgE levels,[2],[3] but this is not a consistent observation. Hence, we performed a study to elucidate the correlation between the severity of AD, the absolute eosinophil count in the blood and the serum IgE levels. To the best of our knowledge, this is the first study of its kind from the Indian subcontinent.


  Materials and methods Top


The study was carried out at the Pediatric Dermatology Clinic, Institute of Child Health and Department of Dermatology, AMRI-Apollo hospitals, Kolkata. A total of 102 consecutive patients, both children and adults, with atopic dermatitis attending the hospitals were enrolled. One hundred and seven age- and sex-matched persons without any personal or family history of atopy were taken as controls. Patients with atopic dermatitis having other systemic diseases were excluded from the study.

For every patient a detailed history was taken, including the age at onset, duration of present illness, personal and/or family history of atopic disorder, and this was recorded in a pro-forma. Written consent was obtained from the subjects or their parents before enrollment.

A thorough clinical examination was carried out to determine the surface area of involvement of the disease (using Wallace's Rule of Nine) and the severity (using the SCORAD index).

The SCORAD index is a scoring system designed by the European Task Force on Atopic Dermatitis to measure the severity of atopic dermatitis. It has five clinical signs, viz. erythema, vesiculation, excoriation, crusting and edema, each of these signs with four scores: 0 = absent; 1 = mild, 2 = moderate, and 3 = severe. The total IgE level and absolute eosinophil count were obtained in each patient.

One way analysis of variance was performed on parameters of severity of atopic dermatitis, eosinophil count and IgE levels with respect to independent variables like sex, family history of atopy (father, mother or both), sex and associated atopic conditions (bronchial asthma, allergic rhinitis). Each of the parameters was compared with each other using Product Moment Correlation to observe any significant covariance.


  Results Top


The baseline demography of the cases and the controls are shown in [Table - 1].

The age of onset of the disease ranged from 6 months to17.5 years, with a mean of 4.55 years (SD 3.63). The severity of atopic dermatitis, as recorded using the SCORAD index, ranged from 10 (maximum possible value, 15) to 1 (minimum possible value, 0), with a mean of 5.48 (SD 2.59). The mean percentage of body surface area involved was 7.07 (SD 5.13). The mean of the total number of attacks of the disease suffered by the patient before presentation was 6 (SD 4.65) and that of the duration of present illness was 3.02 months (SD 1.78). The absolute eosinophil count ranged from 34 to 3453, with a mean of 624 (SD 590), in patients with atopic dermatitis, and from 10 to 512 with a mean of 105 (SD 83) in controls. Serum IgE levels ranged from 22 to 1188 IU, with a mean of 278.2 (SD 324.85), in patients, and from 2 to 126 IU, with a mean of 25.8 IU (SD 23.36), in controls.

The results of the Product Moment Correlation are shown in [Table - 2]. Product Moment Correlation showed that there was significant (p<0.0001) covariance between the severity of atopic dermatitis, total number of episodes, absolute eosinophil count and IgE level. Three parameters, the severity of atopic dermatitis, the absolute eosinophil count and the IgE level, individually showed significant association with a family history of atopy only if both parents were atopic. These parameters also showed a significant association with a history of bronchial asthma in patients of atopic dermatitis but not with a history of allergic rhinitis. The age of onset of the disease was not significantly associated with a personal or a family history of atopy.

One-way analysis of variance performed on the IgE level with respect to the month of estimation showed no significant association. The duration of the disease or the chronicity of the eczema did not correlate with IgE levels and eosinophil count.


  Discussion Top


Hospital based studies suggest that the age of onset of AD is under 6 months in 75% of the cases and before the age of 5 years in 80% to 90%, but occasionally onset may be delayed until later childhood or adult life. [5],[6],[7] In Singapore, a retrospective analysis showed that the onset was before the age of 10 years in 61.2% cases and in 13.6% cases after the age of 21years.[8] In a study from northern India, the age of onset was separately obtained for infantile AD and childhood AD. The mean age of onset in the infantile group was 4.3 months, and that in the childhood group was 4.1 years.[9] We found that the mean age at onset of AD was 4.55 (SD 3.63) years, an observation similar to that of childhood AD in the earlier Indian study.

We also found that in patients with AD the mean absolute eosinophil count was 624 (SD 590) and the mean IgE level was 278.29 (SD 324.85); the corresponding values were 121 (SD 109) and 25.8 (SD 23.36) respectively for controls. Thus, the absolute eosinophil count and the IgE level were significantly higher in patients with AD than in controls.

A Japanese study found that the eosinophil levels roughly correlated with the disease severity, but the pattern of eosinophilia was not homogeneous.[10] Very high eosinophil counts were common in severe cases of AD who had a personal or family history of respiratory atopy, while normal or moderately elevated counts were obtained in severe cases of 'pure' atopic dermatitis who had neither a personal nor a family history of respiratory atopy. It was suggested that disease severity and personal or family history of respiratory atopy are important factors in determining high blood eosinophil levels in atopic dermatitis.[10] Similarly, we found that both the absolute eosinophil count and the IgE level showed significant covariance with disease severity. The non-homogeneous distribution of the absolute eosinophil count and the IgE level were reflected in the large range and higher standard deviation. One way analysis of variance showed a significant association of the absolute eosinophil count and the IgE level with a family history of AD only when both parents were affected. The eosinophil count and the IgE level also showed a significant association with a history of bronchial asthma in patients with AD but not with allergic rhinitis.

A Japanese study evaluated the role of eosinophils in atopic dermatitis by correlating levels of serum eosinophil cationic protein (ECP), clinical activity, eosinophil count and IgE level. [11] A positive correlation was observed between the number of peripheral blood eosinophils and serum ECP levels in severe cases (r = 0.67, p < 0.05). Further, the ECP levels significantly decreased with clinical improvement of AD or decreased numbers of blood hypo-dense eosinophils in anti-allergic drug-treated patients. There was no correlation between serum ECP and IgE levels. These findings indicate that eosinophils may release their granular contents, including ECP, into the peripheral circulation and/or inflammatory skin lesions and subsequently provoke a clinical exacerbation by stimulating allergic reactions.[11] Our study not only show similar results but also highlights a significant association of clinical activity (severity) of AD with IgE levels in the blood.

The age at onset of AD did not show any significant association with associated atopic conditions or with a family history of atopy.

In atopic dermatitis, a Th1/Th2 imbalance has been reported, and interleukin (IL)-13 seems to play a pivotal role in the inflammatory network. Grutta et al assessed the correlation between the immunological marker CD4 (+) cells, interleukin (IL)-13 (+) and the clinical phase of extrinsic AD in children.[12] They found that blood CD4 (+) cells, IL-4 (+) were significantly higher in the AD group than in controls. CD4 (+) IL-13 (+) cells in the AD group correlated well (p = 0.0007) with the SCORAD index. At remission, there was a significant correlation between SCORAD index and eosinophil count (p < 0.03) and the percentage of CD4 (+) IL-13 (+) cells globally decreased (p < 0.0001), while no difference was found among SCORAD classes. This study confirmed the Th2 profile predominance in the peripheral blood of children with AD, and the close relationship between the number of CD4 (+) IL-13 (+) T cells and disease severity.[12]

The elevated IgE response and eosinophilia observed in patients with atopic dermatitis (AD) may reflect increased responses of type 2 T-helper (Th2) cytokines with a concomitant decrease in interferon-gamma (IFN-gamma) production. However, the cross-regulation of Th1/Th2 derivation and function in AD patients are incompletely characterized. Yoshizawa et al investigated serum levels of several cytokines (IL-18, IL-12, IL-10, IL-2 and IFN-gamma) in patients with AD to assess their possible relationship to the severity of disease. Serum IL-18 levels in AD patients were significantly higher than in healthy controls and significantly correlated with eosinophil counts and serum soluble IL-2 receptor (sIL-2R) levels. They showed a tendency to correlate with clinical severity scores and serum IgE levels. IL-2 levels showed a significantly inverse correlation with serum IgE levels, and IL-12 levels clearly correlated with IL-10 levels. These results suggest the value of serum IL-18 levels as a parameter of AD activity and may support a possible role for IL-18 in the pathogenesis of AD. The inverse correlation between IgE levels and IL-2 levels suggests that IgE production may be inhibited by IL-2 in patients with AD.[13]

Our study shows that the clinical activity of AD, as recorded by the SCORAD index, can be used as an indicator of the hematological abnormalities as well as, to some extent, a prognostic indicator in the majority of patients. Family history of atopy is important only if both parents are affected and bronchial asthma is the only associated atopic condition that correlates with the various parameters of the disease.



 
  References Top

1.Ohman S, Johansson SG .Immunoglobins in atopic dermatitis, with special reference to IgE. Acta Derm Venereol 1974;54:193-202.  Back to cited text no. 1  [PUBMED]    
2.Ohman S, Johansson SG. Allergen-specific IgE in atopic dermatitis. Acta Derm Venereol 1974;54:283-90.  Back to cited text no. 2  [PUBMED]    
3.Jones HE, Inouye JC, McGerity JL, Lewis CW. Atopic disease and serum immunoglobin-E. Br J Dermatol 1975;92:17-25.  Back to cited text no. 3  [PUBMED]    
4.Uehara M. Family background of respiratory atopy: a factor of serum IgE elevation in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989;144:78-82  Back to cited text no. 4  [PUBMED]    
5.Musgrove K, Morgan JK. Infantile eczema: a long- term follow up study. Br J Drematol 1976;95:365-72.  Back to cited text no. 5  [PUBMED]    
6.Rajka G. Essential aspect of atopic dermatitis. Berlin: Springer-Verlag; 1989.  Back to cited text no. 6      
7.Vickors CF. The natural history of atopic eczema. Acta Derm Venereol Suppl (Stockh) 1980;92:113-5.  Back to cited text no. 7      
8.Tay YK, Khoo BP, Gol CL. The epidemiology of atopic dermatitis at a tertiary referral skin center in Singapore. Asian Pac J Allergy Immunol 1999;17:137-41.  Back to cited text no. 8      
9.Dhar S, Kanwar AJ. Epidemiology and clinical pattern of atopic dermatitis in a north Indian pediatric population. Pediatric Dermatol 1998;15:347-51.  Back to cited text no. 9      
10.Uehara M, Izukura R, Sawai T. Blood eosinophilia in atopic dermatitis. Clin Exp Dermaotol 1990;15:264-6.  Back to cited text no. 10  [PUBMED]    
11.Tsuda S, Kato k, Miyasto M, Sasai Y. Eosinophil involvement in atopic dermatitis as reflected by elevated serum levels of eosinophil cationic protein. J Dermatol 1992;19:208-13.  Back to cited text no. 11      
12.La Grutta S, Richiusa P, Pizzolanti G, Mattina A, Pajno GB, Citarrella R, et al . CD4(+)IL-13(+) cells in peripheral blood well correlates with the severity of atopic dermatitis in children. Allergy 2005;60:391-5.  Back to cited text no. 12      
13.Yoshizawa Y, Nomaguchi H, Izaki S, Kitamura K. Serum cytokine levels in atopic dermatitis. Clin Exp Dermatol 2002;27:225-9.  Back to cited text no. 13      



 
 
    Tables

  [Table - 1], [Table - 2]

This article has been cited by
1 Guidelines of care for the management of atopic dermatitis
Lawrence F. Eichenfield,Wynnis L. Tom,Sarah L. Chamlin,Steven R. Feldman,Jon M. Hanifin,Eric L. Simpson,Timothy G. Berger,James N. Bergman,David E. Cohen,Kevin D. Cooper,Kelly M. Cordoro,Dawn M. Davis,Alfons Krol,David J. Margolis,Amy S. Paller,Kathryn Schwarzenberger,Robert A. Silverman,Hywel C. Williams,Craig A. Elmets,Julie Block,Christopher G. Harrod,Wendy Smith Begolka,Robert Sidbury
Journal of the American Academy of Dermatology. 2013;
[Pubmed] | [DOI]
2 Effects of magnolialide isolated from the leaves of Laurus nobilis L. (Lauraceae) on immunoglobulin E-mediated type I hypersensitivity in vitro
Taehun Lee,Sooryun Lee,Kyeong Ho Kim,Ki-Bong Oh,Jongheon Shin,Woongchon Mar
Journal of Ethnopharmacology. 2013; 149(2): 550
[Pubmed] | [DOI]
3 Toll-like receptor 2 in patients with atopic dermatitis
Inas Abdel Rasheed,Mahmood F. Abdel Hamid,Mohammed I. Alzorkany,Moshira M. Ali,Ghada A. Abdel Aziz,Rehab M. Abdel Hamid
Medical Research Journal. 2012; 11(2): 27
[Pubmed] | [DOI]
4 Effects of pear ethanol extract on asthma induced by ovalbumin in mice
Hee-Jin Chung, Young-Min Joung, Eu-Gene Choi, Dong-Sung Shin, Hyung-Woo Kim, Su-In Cho
The Korea Journal of Herbology. 2012; 27(1): 11
[VIEW] | [DOI]
5 Systemic Treatment of Pediatric Atopic Dermatitis with Azathioprine and Mycophenolate Mofetil : Systemic Treatment of Pediatric Atopic Dermatitis
Weston T. Waxweiler, Robert Agans, Dean S. Morrell
Pediatric Dermatology. 2011; : no
[VIEW] | [DOI]
6 Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring : IL-31 in paediatric atopic dermatitis: a marker of severity
MHM Ezzat, ZE Hasan, KYA Shaheen
Journal of the European Academy of Dermatology and Venereology. 2011; 25(3): 334
[VIEW] | [DOI]
7 Systemic treatment of pediatric atopic dermatitis with azathioprine and mycophenolate mofetil
Waxweiler, W.T., Agans, R., Morrell, D.S.
Pediatric Dermatology. 2011; 28(6): 689-694
[Pubmed]
8 Inverse association of eosinophil count with colorectal cancer incidence: Atherosclerosis Risk in Communities study
Prizment, A.E., Anderson, K.E., Visvanathan, K., Folsom, A.R.
Cancer Epidemiology Biomarkers and Prevention. 2011; 20(9): 1861-1864
[Pubmed]
9 Atopic dermatitis in infants and children in India
Dhar, S., Banerjee, R.
Indian Journal of Dermatology, Venereology and Leprology. 2010; 76(5): 504-513
[Pubmed]
10 Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis
S. Gerdes,W. Kurrat,U. Mrowietz
British Journal of Dermatology. 2009; 160(4): 736
[Pubmed] | [DOI]
11 Treatment of Atopic Dermatitis With Acupuncture and Chinese Herbal Medicine
Joe C. Chang, Armando González-Stuart
Medical Acupuncture. 2009; 21(1): 55
[VIEW] | [DOI]
12 Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis
Gerdes, S., Kurrat, W., Mrowietz, U.
British Journal of Dermatology. 2009; 160(4): 736-740
[Pubmed]
13 Clinical detection of ichthyosis vulgaris in an atopic dermatitis clinic: Implications for allergic respiratory disease and prognosis
Bremmer, S.F., Hanifin, J.M., Simpson, E.L.
Journal of the American Academy of Dermatology. 2008; 59(1): 72-78
[Pubmed]
14 Clinical detection of ichthyosis vulgaris in an atopic dermatitis clinic: Implications for allergic respiratory disease and prognosis
Sam F. Bremmer,Jon M. Hanifin,Eric L. Simpson
Journal of the American Academy of Dermatology. 2008; 59(1): 72
[Pubmed] | [DOI]
15 Montelukast treatment in children with moderately severe atopic dermatitis
Ehlayel, M.S., Bener, A., Sabbah, A.
European Annals of Allergy and Clinical Immunology. 2007; 39(7): 232-236
[Pubmed]
16 HLA- A, B, DR and DQ alleles study in Tunisian patients with atopic dermatitis | [Etude des alleles HLA - A, B, DR et DQ Tunisian patients with atopic dermatitis]
Affes, H., Mahfoudh, N., Kammoun, A., Masmoudi, A., Marrekchi, S., Turki, H., Makni, H.
Tunisie Medicale. 2007; 85(10): 834-838
[Pubmed]
17 Frequency of raised serum IgE Level in childhood atopic dermatitis
Ahmed, I., Nasreen, S.
Journal of the Pakistan Medical Association. 2007; 57(9): 431-434
[Pubmed]
18 A meta-analysis of randomized, placebo-controlled clinical trials of Efamol® evening primrose oil in atopic eczema. Where do we go from here in light of more recent discoveries?
Morse NL, Clough PM
Current Pharmaceutical Biotechnology. 2006; 7(6): 503-524
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow